Skip to content
★ Sign in to follow
ED

Eilon D. Kirson

Novocure Ltd
Total declarations
39
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (19 ops.)
€20.8M

Latest filing published 01 Mar 2019 for Novocure Ltd, €322k.

Filing timeline

BuySale
Eilon D. Kirson

Insider track record

Disclosed buys
0
Disclosed sells
19
Signal history

Eilon D. Kirson: trading record in brief

This profile gathers the share dealings of Eilon D. Kirson in Novocure Ltd. We count 39 filings; the first trade dates from 18 April 2016 and the latest from 27 February 2019.

No open-market purchase appears, only 19 sales worth €20.8M. Other entries cover 2 share grants and 14 option exercises. 2019 to date brings no purchases and 2 sales.

The newest entry dates from 1 March 2019: an option exercise of €322k, in Novocure Ltd. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Eilon D. Kirson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations39 total
  • ◇
    Chief Science OfficerExecutivesNovocure Ltd
    367,391 USD11SEC
    6,945 shares@ US$52.901.2% of flowOrdinary SharesSEC:0001209191-19-015000:0
  • ◇
    Chief Science OfficerExecutivesNovocure Ltd
    2M USD12SEC
    36,400 shares@ US$53.386.4% of flowOrdinary SharesSEC:0001209191-19-013680:0
  • ◇
    Chief Science OfficerExecutivesNovocure Ltd
    1M USD11SEC
    100,000 shares@ US$14.374.7% of flowOrdinary SharesSEC:0001209191-19-004549:0
  • ▼
    Chief Science OfficerExecutivesNovocure Ltd
    5M USD30SEC
    100,000 shares@ US$45.1114.8% of flowOrdinary SharesSEC:0001209191-19-004549:1
  • ◇
    Chief Science OfficerExecutivesNovocure Ltd
    988,843 USD11SEC
    68,813 shares@ US$14.373.3% of flowOrdinary SharesSEC:0001209191-19-004549:2
  • ▼
    Chief Science OfficerExecutivesNovocure Ltd
    3M USD30SEC
    68,813 shares@ US$45.2510.3% of flowOrdinary SharesSEC:0001209191-19-004549:3
  • ◆
    Chief Science OfficerExecutivesNovocure Ltd
    21,247 USD11SEC
    1,231 shares@ US$17.260.1% of flowOrdinary SharesSEC:0001209191-18-042137:0
  • ◇
    Chief Science OfficerExecutivesNovocure Ltd
    441,878 USD11SEC
    30,750 shares@ US$14.371.2% of flowOrdinary SharesSEC:0001209191-18-038050:0
  • ◇
    Chief Science OfficerExecutivesNovocure Ltd
    429,750 USD11SEC
    37,500 shares@ US$11.461.1% of flowOrdinary SharesSEC:0001209191-18-038050:1
  • ◇
    Chief Science OfficerExecutivesNovocure Ltd
    2M USD11SEC
    218,781 shares@ US$7.034.1% of flowOrdinary SharesSEC:0001209191-18-036127:0
  • ▼
    Chief Science OfficerExecutivesNovocure Ltd
    6M USD31SEC
    225,296 shares@ US$28.6017.4% of flowOrdinary SharesSEC:0001209191-18-036127:1
  • ◇
    Chief Science OfficerExecutivesNovocure Ltd
    442,292 USD11SEC
    59,130 shares@ US$7.481.2% of flowOrdinary SharesSEC:0001209191-18-036127:2
  • ◇
    Chief Science OfficerExecutivesNovocure Ltd
    487,988 USD11SEC
    68,250 shares@ US$7.151.3% of flowOrdinary SharesSEC:0001209191-18-036127:3
  • ▼
    Chief Science OfficerExecutivesNovocure Ltd
    3M USD30SEC
    114,934 shares@ US$29.369.1% of flowOrdinary SharesSEC:0001209191-18-036127:4
  • ▼
    Chief Science OfficerExecutivesNovocure Ltd
    54,468 USD29SEC
    1,800 shares@ US$30.260.1% of flowOrdinary SharesSEC:0001209191-18-036127:5
  • ▼
    Chief Science OfficerExecutivesNovocure Ltd
    131,118 USD29SEC
    4,131 shares@ US$31.740.4% of flowOrdinary SharesSEC:0001209191-18-036127:6
  • ◇
    Chief Science OfficerExecutivesNovocure Ltd
    264,429 USD11SEC
    76,869 shares@ US$3.440.7% of flowOrdinary SharesSEC:0001209191-18-025732:0
  • ▼
    Chief Science OfficerExecutivesNovocure Ltd
    2M USD26SEC
    76,869 shares@ US$24.004.7% of flowOrdinary SharesSEC:0001209191-18-025732:1
  • ◇
    Chief Science OfficerExecutivesNovocure Ltd
    244,089 USD11SEC
    70,956 shares@ US$3.440.6% of flowOrdinary SharesSEC:0001209191-18-025732:2
  • ▼
    Chief Science OfficerExecutivesNovocure Ltd
    2M USD26SEC
    70,956 shares@ US$24.004.3% of flowOrdinary SharesSEC:0001209191-18-025732:3
  • ◇
    Chief Science OfficerExecutivesNovocure Ltd
    784,442 USD11SEC
    36,401 shares@ US$21.552.0% of flowOrdinary SharesSEC:0001209191-18-013425:0
  • ▼
    Chief Science OfficerExecutivesNovocure Ltd
    557,040 USD26SEC
    25,320 shares@ US$22.001.5% of flowOrdinary SharesSEC:0001209191-18-003629:0
  • ▼
    Chief Science OfficerExecutivesNovocure Ltd
    200,200 USD29SEC
    9,100 shares@ US$22.000.5% of flowOrdinary SharesSEC:0001209191-17-059742:0
  • ▼
    Chief Science OfficerExecutivesNovocure Ltd
    6,600 USD29SEC
    300 shares@ US$22.000.0% of flowOrdinary SharesSEC:0001209191-17-059404:0
  • ▼
    Chief Science OfficerExecutivesNovocure Ltd
    68,200 USD29SEC
    3,100 shares@ US$22.000.2% of flowOrdinary SharesSEC:0001209191-17-059404:1

25 of 39 declarations